News from united therapeutics corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 03, 2021, 06:00 ET United Therapeutics Corporation Reports Third Quarter 2021 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today...

Nov 01, 2021, 06:00 ET United Therapeutics Corporation To Present At The Credit Suisse 30th Annual Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Michael Benkowitz, President and Chief Operating Officer of United Therapeutics,...

Oct 27, 2021, 06:00 ET United Therapeutics Corporation To Report Third Quarter 2021 Financial Results Before The Market Opens On Wednesday, November 3, 2021

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2021 financial results before the market opens...

Oct 21, 2021, 06:00 ET United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today detailed ...

Oct 18, 2021, 06:00 ET United Therapeutics Provides an Update on the Progress of the Tyvaso DPI™ New Drug Application

United Therapeutics Corporation (Nasdaq: UTHR) today announced an update on the U.S. Food and Drug Administration (FDA) review of the new drug...

Oct 11, 2021, 06:00 ET United Therapeutics to Present New Data at CHEST Annual Meeting 2021

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today...

Sep 30, 2021, 16:30 ET United Therapeutics Converts to a Public Benefit Corporation Following Shareholder Approval

United Therapeutics Corporation (Nasdaq: UTHR) today announced it has officially converted to a public benefit corporation (PBC). The conversion...

Sep 10, 2021, 06:00 ET United Therapeutics Releases its Annual Corporate Responsibility Report

United Therapeutics Corporation (Nasdaq: UTHR) today announced the release of its second annual Corporate Responsibility Report with 2020 highlights, ...

Sep 07, 2021, 06:00 ET United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021

United Therapeutics Corporation (Nasdaq: UTHR) today presented new clinical data from the BREEZE study evaluating Tyvaso DPI™ (treprostinil) in...

Aug 25, 2021, 06:00 ET United Therapeutics Partners with Former NFL Player Devon Still and His Daughter Leah to Launch "Braving NeuroBLASToma" in Honor of Childhood Cancer Awareness Month

United Therapeutics Corporation (Nasdaq: UTHR) today announced it is joining forces with former NFL player Devon Still and his daughter Leah, a...

Aug 24, 2021, 06:00 ET United Therapeutics to Present Tyvaso DPI™ BREEZE Clinical Data at the European Respiratory Society International Congress 2021

United Therapeutics Corporation (Nasdaq: UTHR) today announced it will present data from a clinical trial studying Tyvaso DPI™ (treprostinil) in...

Aug 04, 2021, 06:00 ET United Therapeutics Corporation Reports Second Quarter 2021 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended June 30, 2021. Total revenue in the second ...

Aug 03, 2021, 06:00 ET United Therapeutics Corporation To Present At The 2021 Wedbush PacGrow Healthcare Virtual Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer of United...

Jul 28, 2021, 06:00 ET United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its second quarter 2021 financial results before the market opens...

Jun 30, 2021, 06:00 ET United Therapeutics Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE Study

United Therapeutics Corporation (Nasdaq: UTHR) today announced the publication in The Lancet Respiratory Medicine of a post-hoc analysis of forced...

Jun 16, 2021, 06:00 ET United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review

United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) accepted for priority review the New...

Jun 07, 2021, 06:00 ET United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it is pursuing additional claims for trade secret misappropriation against...

Jun 03, 2021, 06:00 ET United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary Fibrosis

United Therapeutics Corporation (Nasdaq: UTHR) announced today that the first patient has enrolled in the phase 3 TETON study, which is expected to...

May 25, 2021, 06:00 ET United Therapeutics Corporation To Present At The Jefferies Virtual Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Mr. James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, ...

May 05, 2021, 06:00 ET United Therapeutics Corporation Reports First Quarter 2021 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended March 31, 2021. Total revenue in the first ...

Apr 26, 2021, 06:00 ET United Therapeutics Corporation To Report First Quarter 2021 Financial Results Before The Market Opens On Wednesday, May 5, 2021

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2021 financial results before the market opens...

Apr 19, 2021, 06:00 ET United Therapeutics Announces Submission of Tyvaso DPI™ New Drug Application to FDA

United Therapeutics Corporation (Nasdaq: UTHR) today announced the submission of a new drug application (NDA) to the U.S. Food and Drug...

Apr 01, 2021, 06:00 ET United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has approved Tyvaso® (treprostinil)...

Mar 24, 2021, 06:00 ET United Therapeutics Corporation To Present At The 10th Annual J.P. Morgan Napa Valley Forum

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Gil Golden, Executive Vice President and Chief Medical Officer of United...

Mar 09, 2021, 06:00 ET United Therapeutics Corporation To Present At The Oppenheimer 31st Annual Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairman and Chief Executive Officer of United...